We also documented the cytotoxic effects of NVP-BAG956 and MK-2006 against a T-ALL cell subpopulation (CD34+/CD7,−/CD4−) enriched for cancer stem cells (or leukemia initiating cells, LICs). Here, CD7 is linked to acute lymphoblastic leukemia.